OA01.05 Phase I Dose Escalation Trial Of The DLL3/CD3 Igg-Like T Cell Engager BI 764532 In Patients with DLL3+ Tumors: Focus on SCLC
| Autor: | Wermke, M., Kuboki, Y., Felip, E., Alese, O.B., Morgensztern, D., Sayehli, C., Arriola, E., Sanmamed, M.F., Oum’ Hamed, Z., Song, E., Studeny, M., Gambardella, V. |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology November 2023 18(11) Supplement:S45-S46 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|